GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SS Innovations International Inc (OTCPK:SSII) » Definitions » Days Sales Outstanding

SS Innovations International (SS Innovations International) Days Sales Outstanding : 105.74 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is SS Innovations International Days Sales Outstanding?

SS Innovations International's average Accounts Receivable for the three months ended in Dec. 2023 was $1.58 Mil. SS Innovations International's Revenue for the three months ended in Dec. 2023 was $1.36 Mil. Hence, SS Innovations International's Days Sales Outstanding for the three months ended in Dec. 2023 was 105.74.

The historical rank and industry rank for SS Innovations International's Days Sales Outstanding or its related term are showing as below:

SSII' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.49   Med: 108.85   Max: 148.2
Current: 100.71

During the past 8 years, SS Innovations International's highest Days Sales Outstanding was 148.20. The lowest was 69.49. And the median was 108.85.

SSII's Days Sales Outstanding is ranked worse than
79.31% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.66 vs SSII: 100.71

SS Innovations International's Days Sales Outstanding increased from Dec. 2022 (37.05) to Dec. 2023 (105.74).


SS Innovations International Days Sales Outstanding Historical Data

The historical data trend for SS Innovations International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SS Innovations International Days Sales Outstanding Chart

SS Innovations International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial - - - 148.20 69.49

SS Innovations International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.05 - 61.99 82.38 105.74

Competitive Comparison of SS Innovations International's Days Sales Outstanding

For the Medical Devices subindustry, SS Innovations International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SS Innovations International's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where SS Innovations International's Days Sales Outstanding falls into.



SS Innovations International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

SS Innovations International's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.592 + 1.647) / 2 ) / 5.88*365
=1.1195 / 5.88*365
=69.49

SS Innovations International's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1.512 + 1.647) / 2 ) / 1.363*365 / 4
=1.5795 / 1.363*365 / 4
=105.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SS Innovations International  (OTCPK:SSII) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


SS Innovations International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of SS Innovations International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


SS Innovations International (SS Innovations International) Business Description

Traded in Other Exchanges
N/A
Address
1500 SE 15th Street, Suite 512, Fort Lauderdale, FL, USA, 33316
SS Innovations International Inc, formerly Avra Medical Robotics Inc develops medical-surgical devices. It invests in four areas including surgical robotic systems, surgical tools, implantable devices, and surgical robotic training. It is a medical robotics company developing a fully autonomous medical robotic system using proprietary software which integrates Artificial Intelligence and Deep Learning, or machine learning. By using an AI and DL-enhanced software program, the company is creating an intelligent robotic system that it believes can robotize a wide range of medical procedures currently being performed by human hands.
Executives
Barry F Cohen director, officer: COO 1600 SOUTHEAST 15TH STREET, APT 512, FORT LAUDERDALE FL 33316
Sudhir Srivastava director, 10 percent owner, officer: Chairman and CEO C/O AVRA SURGICAL ROBOTICS, ONE LIBERTY PLAZA, 35TH FLOOR, NEW YORK NY 10006
Kumar Sethi Anup officer: Chief Financial Officer C-102, DREAM APARTMENTS,, PLOT-14, SECTOR 22, DWARKA, NEW DEHLI K7 110077
Pascual Srivastava Vishwajyoti officer: President 28 HAARBAA, TRIAVENI GARDENS COMPLEX, GADAIPUR MEHRA, NEW DEHLI K7 110030
Sampige Prasannakumar Somashekar director APT 9J, NEST NO 8, 303 LG HALFI, RMV II, BANGALORE K7 560094
Annadurai Mylswamy director #344, NTI LAYOUT, 10TH MAIN, VIDHYARANYAPURA, BANGALORE K7 560067